Company Updates

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has completed recruitment of patients into Part B of its phase

With Prof. Dr. Ralf Wandmacher, a well-known personality in blockchain technology and banking strengthens the Board of Directors of Coinmat AG. 

Dr George Dimistroulis (Surgeon and Founder OMX-Solutions) joined a world-renowned international faculty to present on the initial findings of the first 16 implantations of the OsseoFrame. 

Cirrus announces a second fusion energy sub-contract to provide “quench layer” coating technology to the world leader in premium superconducting wire.

Mosaic Solutions, a Philippines-based tech startup that provides profit optimization solutions for the hospitality industry, announced that is has raised $350,000 of its targeted $1mm current round.

Cirrus is excited to announce that we have agreed a sub-contract through to the US Department of Energy to work on advanced materials technology in support of fusion energy development

The Series A will be about a $6 – $7 share price (tbc). The goal is to close this either in Q4 of 2019 or Q1 of 2020 (as soon as we reach 10k users).

Elixinol Global Ltd is pleased to announce that its wholly-owned subsidiary, Elixinol LLC (Elixinol), has entered into a manufacturing and supply agreement with Altmed Pets, LLC, trading a Pet Releaf

St Jude’s Hospital article on phase I trial using GDC-0084 to treat the deadly children’s brain cancer, DIPG